Business Wire: July 26, 2017 – NEW YORK, NY, U.S.A. – Ophthotech Corporation (Nasdaq: OPHT) today announced that the company is pursuing a strategy to leverage its clinical experience and retina expertise to identify and develop therapies to treat multiple orphan ophthalmic diseases for which there…
